Postheparin plasma lipolytic activities in physically active and sedentary men after varying and repeated doses of intravenous heparin

Paul D. Thompson, Mark A. Kantor, Eileen M. Cullinane, Stanley P. Sady, Ann Saritelli, Peter N. Herbert

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

We sought to determine the optimal dose of heparin for evaluating the activities of lipoprotein lipase (LPLA) and hepatic triglyceride hydrolase (HTGLA) in postheparin plasma. Nine physically active and ten sedentary men (age 30 ± 5 yr, mean ± SD) received 30, 50, 75, and 100 IU/kg of heparin in random order during a 2-week period. Based on all the samples, the average LPLA in the athletes was 43% higher (P < 0.001) and HTGLA was 19% lower than in the untrained subjects (NS). The greatest LPLA was obtained after a heparin dose of 75 IU/kg, but LPLA after the three highest doses were not significantly different. There was also a dose effect on HTGLA (P < 0.001) with greatest activities following doses of 75 and 100 IU/kg. Despite these dose effects, subjects maintained their rank order for both postheparin lipase activities regardless of the heparin dose. The only exception was for LPLA in the sedentary men probably because of lower LPLA and a smaller range of values. We also examined the effect of repeated daily injections of 75 IU/kg heparin on LPLA, HTGLA, and serum lipids. Repeated heparin administration on three consecutive days produced no significant effects on the apparent lipase activities. When all subjects were combined, HDL-cholesterol was increased over time (P < 0.05) due to increases in both the HDL2 (P < 0.05) and HDL3-cholesterol (NS) subfractions. Infusion of heparin or saline on three consecutive days into 18 additional men, however, had no effect on any lipid parameter. We conclude that 75 IU/kg is as effective as 100 IU/kg of heparin for releasing LPLA and HTGLA and that the relative rank for lipase activities among subjects with a wide range of values is not affected by the heparin dose. Repeated heparin injections do not alter postheparin plasma lipase activities or lipid and lipoprotein concentrations measured on subsequent days.

Original languageEnglish (US)
Pages (from-to)999-1004
Number of pages6
JournalMetabolism
Volume35
Issue number11
DOIs
StatePublished - 1986
Externally publishedYes

Fingerprint

Lipoprotein Lipase
Heparin
Hydrolases
Triglycerides
Liver
Lipase
Lipids
HDL Cholesterol
Lipoprotein(a)
Injections
Athletes
Lipoproteins

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Postheparin plasma lipolytic activities in physically active and sedentary men after varying and repeated doses of intravenous heparin. / Thompson, Paul D.; Kantor, Mark A.; Cullinane, Eileen M.; Sady, Stanley P.; Saritelli, Ann; Herbert, Peter N.

In: Metabolism, Vol. 35, No. 11, 1986, p. 999-1004.

Research output: Contribution to journalArticle

Thompson, Paul D. ; Kantor, Mark A. ; Cullinane, Eileen M. ; Sady, Stanley P. ; Saritelli, Ann ; Herbert, Peter N. / Postheparin plasma lipolytic activities in physically active and sedentary men after varying and repeated doses of intravenous heparin. In: Metabolism. 1986 ; Vol. 35, No. 11. pp. 999-1004.
@article{0a652b7aecfb416585ac7d5c992a93c0,
title = "Postheparin plasma lipolytic activities in physically active and sedentary men after varying and repeated doses of intravenous heparin",
abstract = "We sought to determine the optimal dose of heparin for evaluating the activities of lipoprotein lipase (LPLA) and hepatic triglyceride hydrolase (HTGLA) in postheparin plasma. Nine physically active and ten sedentary men (age 30 ± 5 yr, mean ± SD) received 30, 50, 75, and 100 IU/kg of heparin in random order during a 2-week period. Based on all the samples, the average LPLA in the athletes was 43{\%} higher (P < 0.001) and HTGLA was 19{\%} lower than in the untrained subjects (NS). The greatest LPLA was obtained after a heparin dose of 75 IU/kg, but LPLA after the three highest doses were not significantly different. There was also a dose effect on HTGLA (P < 0.001) with greatest activities following doses of 75 and 100 IU/kg. Despite these dose effects, subjects maintained their rank order for both postheparin lipase activities regardless of the heparin dose. The only exception was for LPLA in the sedentary men probably because of lower LPLA and a smaller range of values. We also examined the effect of repeated daily injections of 75 IU/kg heparin on LPLA, HTGLA, and serum lipids. Repeated heparin administration on three consecutive days produced no significant effects on the apparent lipase activities. When all subjects were combined, HDL-cholesterol was increased over time (P < 0.05) due to increases in both the HDL2 (P < 0.05) and HDL3-cholesterol (NS) subfractions. Infusion of heparin or saline on three consecutive days into 18 additional men, however, had no effect on any lipid parameter. We conclude that 75 IU/kg is as effective as 100 IU/kg of heparin for releasing LPLA and HTGLA and that the relative rank for lipase activities among subjects with a wide range of values is not affected by the heparin dose. Repeated heparin injections do not alter postheparin plasma lipase activities or lipid and lipoprotein concentrations measured on subsequent days.",
author = "Thompson, {Paul D.} and Kantor, {Mark A.} and Cullinane, {Eileen M.} and Sady, {Stanley P.} and Ann Saritelli and Herbert, {Peter N.}",
year = "1986",
doi = "10.1016/0026-0495(86)90035-1",
language = "English (US)",
volume = "35",
pages = "999--1004",
journal = "Metabolism: Clinical and Experimental",
issn = "0026-0495",
publisher = "W.B. Saunders Ltd",
number = "11",

}

TY - JOUR

T1 - Postheparin plasma lipolytic activities in physically active and sedentary men after varying and repeated doses of intravenous heparin

AU - Thompson, Paul D.

AU - Kantor, Mark A.

AU - Cullinane, Eileen M.

AU - Sady, Stanley P.

AU - Saritelli, Ann

AU - Herbert, Peter N.

PY - 1986

Y1 - 1986

N2 - We sought to determine the optimal dose of heparin for evaluating the activities of lipoprotein lipase (LPLA) and hepatic triglyceride hydrolase (HTGLA) in postheparin plasma. Nine physically active and ten sedentary men (age 30 ± 5 yr, mean ± SD) received 30, 50, 75, and 100 IU/kg of heparin in random order during a 2-week period. Based on all the samples, the average LPLA in the athletes was 43% higher (P < 0.001) and HTGLA was 19% lower than in the untrained subjects (NS). The greatest LPLA was obtained after a heparin dose of 75 IU/kg, but LPLA after the three highest doses were not significantly different. There was also a dose effect on HTGLA (P < 0.001) with greatest activities following doses of 75 and 100 IU/kg. Despite these dose effects, subjects maintained their rank order for both postheparin lipase activities regardless of the heparin dose. The only exception was for LPLA in the sedentary men probably because of lower LPLA and a smaller range of values. We also examined the effect of repeated daily injections of 75 IU/kg heparin on LPLA, HTGLA, and serum lipids. Repeated heparin administration on three consecutive days produced no significant effects on the apparent lipase activities. When all subjects were combined, HDL-cholesterol was increased over time (P < 0.05) due to increases in both the HDL2 (P < 0.05) and HDL3-cholesterol (NS) subfractions. Infusion of heparin or saline on three consecutive days into 18 additional men, however, had no effect on any lipid parameter. We conclude that 75 IU/kg is as effective as 100 IU/kg of heparin for releasing LPLA and HTGLA and that the relative rank for lipase activities among subjects with a wide range of values is not affected by the heparin dose. Repeated heparin injections do not alter postheparin plasma lipase activities or lipid and lipoprotein concentrations measured on subsequent days.

AB - We sought to determine the optimal dose of heparin for evaluating the activities of lipoprotein lipase (LPLA) and hepatic triglyceride hydrolase (HTGLA) in postheparin plasma. Nine physically active and ten sedentary men (age 30 ± 5 yr, mean ± SD) received 30, 50, 75, and 100 IU/kg of heparin in random order during a 2-week period. Based on all the samples, the average LPLA in the athletes was 43% higher (P < 0.001) and HTGLA was 19% lower than in the untrained subjects (NS). The greatest LPLA was obtained after a heparin dose of 75 IU/kg, but LPLA after the three highest doses were not significantly different. There was also a dose effect on HTGLA (P < 0.001) with greatest activities following doses of 75 and 100 IU/kg. Despite these dose effects, subjects maintained their rank order for both postheparin lipase activities regardless of the heparin dose. The only exception was for LPLA in the sedentary men probably because of lower LPLA and a smaller range of values. We also examined the effect of repeated daily injections of 75 IU/kg heparin on LPLA, HTGLA, and serum lipids. Repeated heparin administration on three consecutive days produced no significant effects on the apparent lipase activities. When all subjects were combined, HDL-cholesterol was increased over time (P < 0.05) due to increases in both the HDL2 (P < 0.05) and HDL3-cholesterol (NS) subfractions. Infusion of heparin or saline on three consecutive days into 18 additional men, however, had no effect on any lipid parameter. We conclude that 75 IU/kg is as effective as 100 IU/kg of heparin for releasing LPLA and HTGLA and that the relative rank for lipase activities among subjects with a wide range of values is not affected by the heparin dose. Repeated heparin injections do not alter postheparin plasma lipase activities or lipid and lipoprotein concentrations measured on subsequent days.

UR - http://www.scopus.com/inward/record.url?scp=0023009543&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023009543&partnerID=8YFLogxK

U2 - 10.1016/0026-0495(86)90035-1

DO - 10.1016/0026-0495(86)90035-1

M3 - Article

VL - 35

SP - 999

EP - 1004

JO - Metabolism: Clinical and Experimental

JF - Metabolism: Clinical and Experimental

SN - 0026-0495

IS - 11

ER -